Last updated: February 16, 2009
Sponsor: Bozyaka Training and Research Hospital
Overall Status: Trial Status Unknown
Phase
2/3
Condition
Bladder Cancer
Urothelial Cancer
Treatment
N/AClinical Study ID
NCT00816075
URO-DW-1971
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
pathologic finding of superficial bladder cancer within the intermediate risk group
recurred after 6 months from the primary tumor
those patients who were included in our follow-up program since 2002 and whose recordscould be obtained.
Exclusion
Exclusion Criteria:
carcinoma in situ
any form of intracavitary maintenance therapy
any form of bladder cancer other than transitional cell type
Study Design
Total Participants: 40
Study Start date:
February 01, 2009
Estimated Completion Date:
April 30, 2011
Study Description
Connect with a study center
Bozyaka Training and Research Hospital Urology Clinic
Izmir,
TurkeySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.